Visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection remains a major problem in Ethiopia, India, and Brazil. Tuberculosis (TB), a treatable factor, could contribute to high mortality (up to 25%) in VL-HIV coinfection. However, the current evidence on the prevalence and clinical impact of TB in VL-HIV coinfection is very limited. In previous reports on routine care, TB prevalence ranged from 5.7% to 29.7%, but information on how and when TB was diagnosed was lacking.
Open Forum Infectious Diseases - 1 Apr 2018
MSF calls on warring parties to respect medical facilities in South Sudan as the humanitarian organization is forced to evacuate staff againMSF is gravely concerned about an imminent attack on the town of Leer in South Sudan, and the potential impact on civilians and medical facilities. Press Release - 9 May 2015
Increased access to diagnosis and treatment of HIV-VL co-infection is imperative for eliminating kala azarFast-tracked development of integrated kala azar and HIV guidelines needed Press Release - 1 Dec 2014
Independent medical humanitarian assistance
We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.Learn more